Ureteral Access Sheath Market By Type (Fr below 10, Fr 10-12, Fr 13-15) , By End User (Hospital, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

Ureteral Access Sheath Market

The ureteral access sheath market was valued at $1,293.6 million in 2023 and is estimated to reach $2,412.46 million by 2035, exhibiting a CAGR of 5.31% from 2024 to 2035

A ureteral access sheath is crucial equipment in urological procedures specifically used in interventions involving the urinary tract and kidneys. It is a flexible tube inserted into the ureter to form a path for other instruments, such as lasers and scopes, during minimally invasive surgeries such as ureteroscopy. The sheath enables repeated insertion and removal of instruments without causing any harm, which is beneficial in cases with multiple interventions or prolonged procedures. The easy access to the kidney and ureter offered by ureteral access sheath enables urologists to perform complex procedures with high precision and efficiency. According to research, ureteral access sheath lowers intraoperative intrarenal pressure and temperature by enhancing irrigation outflow during surgeries.

Increase in prevalence of kidney stone, developing healthcare infrastructure, and surge in adoption of minimally invasive procedures are the major drivers of the ureteral access sheath market. The cases of kidney stones have surged over the past few years due to unhealthy dietary habits and rise in obesity, dehydration, & metabolic disorders. As per a factsheet released by the Center of Disease Control and Prevention this year, around 6 million individuals are suffering from kidney stone in the U.S. Ureteral access sheaths play a crucial role in the treatment of such diseases, thereby witnessing a boost in demand.

However, the placement of ureteral access sheath is highly complex which requires significant training and practice. Incorrect placement usually leads to severe complications, hence constraining the market development. Moreover, there are several substitute approaches for the treatment of urinary diseases such as retrograde intrarenal surgery that do not use the sheath, hence limiting its adoption. Contrarily, according to a poster presented at the American Urological Association 2024 (AUA 2024) annual meeting, preoperative administration of tamsulosin, a medication which relaxes the prostate & bladder neck muscles, is able to successfully place the ureteral access sheath for treating kidney stones.

Segment Review

The global ureteral access sheath market is segmented into type, end user, and region. By type, the market is divided into Fr below 10, Fr 10-12, and Fr 13-15. On the basis of end user, it is classified into hospitals, specialty clinics, and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the Fr below 10 segment dominated the market in 2023.

On the basis of end user, the specialty clinics segment acquired a high market share in 2023.

In North America, the market is robust, owing to mature healthcare system, and significant investments in R&D.

Competition Analysis

The major players operating in the ureteral access sheath market are Boston Scientific, Cook Medical, Coloplast Corp, Olympus Corporation, Karl Storz, Oscor Inc, Richard Wolf, Cogentix Medical, Becton, Dickinson and Company, and Envaste Ltd. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

Fr below 10
Fr 10-12
Fr 13-15

By End User

Hospital
Specialty Clinics
Ambulatory Surgical Centers

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Boston Scientific Corporation
Cook Group
Coloplast Corp.
Olympus Corporation
Oscor Inc.
Karl Storz Endoscopy GmbH
Richard Wolf GmbH
COGENTIX MEDICAL
Becton, Dickinson and Company
Envaste Ltd

Product Code: A66217

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: URETERAL ACCESS SHEATH MARKET, BY TYPE

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
4.2. Fr Below 10
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Fr 10-12
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Fr 13-15
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country

CHAPTER 5: URETERAL ACCESS SHEATH MARKET, BY END USER

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
5.2. Hospital
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Specialty Clinics
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4. Ambulatory Surgical Centers
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country

CHAPTER 6: URETERAL ACCESS SHEATH MARKET, BY REGION

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Type
- 6.2.3. Market Size and Forecast, By End User
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Ureteral Access Sheath Market
  - 6.2.5.1. Market Size and Forecast, By Type
  - 6.2.5.2. Market Size and Forecast, By End User
- 6.2.6. Canada Ureteral Access Sheath Market
  - 6.2.6.1. Market Size and Forecast, By Type
  - 6.2.6.2. Market Size and Forecast, By End User
- 6.2.7. Mexico Ureteral Access Sheath Market
  - 6.2.7.1. Market Size and Forecast, By Type
  - 6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Type
- 6.3.3. Market Size and Forecast, By End User
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. Germany Ureteral Access Sheath Market
  - 6.3.5.1. Market Size and Forecast, By Type
  - 6.3.5.2. Market Size and Forecast, By End User
- 6.3.6. France Ureteral Access Sheath Market
  - 6.3.6.1. Market Size and Forecast, By Type
  - 6.3.6.2. Market Size and Forecast, By End User
- 6.3.7. UK Ureteral Access Sheath Market
  - 6.3.7.1. Market Size and Forecast, By Type
  - 6.3.7.2. Market Size and Forecast, By End User
- 6.3.8. Italy Ureteral Access Sheath Market
  - 6.3.8.1. Market Size and Forecast, By Type
  - 6.3.8.2. Market Size and Forecast, By End User
- 6.3.9. Spain Ureteral Access Sheath Market
  - 6.3.9.1. Market Size and Forecast, By Type
  - 6.3.9.2. Market Size and Forecast, By End User
- 6.3.10. Rest of Europe Ureteral Access Sheath Market
  - 6.3.10.1. Market Size and Forecast, By Type
  - 6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Type
- 6.4.3. Market Size and Forecast, By End User
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. Japan Ureteral Access Sheath Market
  - 6.4.5.1. Market Size and Forecast, By Type
  - 6.4.5.2. Market Size and Forecast, By End User
- 6.4.6. China Ureteral Access Sheath Market
  - 6.4.6.1. Market Size and Forecast, By Type
  - 6.4.6.2. Market Size and Forecast, By End User
- 6.4.7. Australia Ureteral Access Sheath Market
  - 6.4.7.1. Market Size and Forecast, By Type
  - 6.4.7.2. Market Size and Forecast, By End User
- 6.4.8. India Ureteral Access Sheath Market
  - 6.4.8.1. Market Size and Forecast, By Type
  - 6.4.8.2. Market Size and Forecast, By End User
- 6.4.9. South Korea Ureteral Access Sheath Market
  - 6.4.9.1. Market Size and Forecast, By Type
  - 6.4.9.2. Market Size and Forecast, By End User
- 6.4.10. Rest of Asia-Pacific Ureteral Access Sheath Market
  - 6.4.10.1. Market Size and Forecast, By Type
  - 6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Type
- 6.5.3. Market Size and Forecast, By End User
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Ureteral Access Sheath Market
  - 6.5.5.1. Market Size and Forecast, By Type
  - 6.5.5.2. Market Size and Forecast, By End User
- 6.5.6. Saudi Arabia Ureteral Access Sheath Market
  - 6.5.6.1. Market Size and Forecast, By Type
  - 6.5.6.2. Market Size and Forecast, By End User
- 6.5.7. South Africa Ureteral Access Sheath Market
  - 6.5.7.1. Market Size and Forecast, By Type
  - 6.5.7.2. Market Size and Forecast, By End User
- 6.5.8. Rest of LAMEA Ureteral Access Sheath Market
  - 6.5.8.1. Market Size and Forecast, By Type
  - 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

8.1. Boston Scientific Corporation
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
8.2. Cook Group
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
8.3. Coloplast Corp.
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
8.4. Olympus Corporation
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
8.5. Oscor Inc.
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
8.6. Karl Storz Endoscopy GmbH
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
8.7. Richard Wolf GmbH
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
8.8. COGENTIX MEDICAL
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
8.9. Becton, Dickinson And Company
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
8.10. Envaste Ltd
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments